Mckesson (MCK) Other Accumulated Expenses (2009 - 2010)
Mckesson (MCK) reported Other Accumulated Expenses of $1.9 billion for Q4 2010, down 22.22% year-over-year from $2.4 billion in Q4 2009, and up 33.95% quarter-over-quarter from $1.4 billion in Q3 2010.
Mckesson (MCK) Other Accumulated Expenses (2009 - 2010) Analysis & Trends
Mckesson (MCK) has 2 years of Other Accumulated Expenses data on file, last reported at $1.9 billion in Q4 2010.
- Other Accumulated Expenses for Q4 2010 came in at $1.9 billion, down 22.22% year-over-year; the trailing twelve-month figure through Dec 2010 was $1.9 billion (down 22.22% YoY), and the FY2010 annual result was $1.6 billion, down 37.71% from the prior year.
- Other Accumulated Expenses grew to $1.9 billion in Q4 2010 per MCK's latest filing, from $1.4 billion in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $2.5 billion in Q3 2009 and troughed at $1.4 billion in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 1.89 Bn |
| Sep 30, 2010 | 1.41 Bn |
| Jun 30, 2010 | 2.43 Bn |
| Mar 31, 2010 | 1.56 Bn |
| Dec 31, 2009 | 2.43 Bn |
| Sep 30, 2009 | 2.52 Bn |
| Jun 30, 2009 | 2.48 Bn |
| Mar 31, 2009 | 2.50 Bn |